Georgia Lee Hampshire, 27, was taking up to 14g of a drug every day at the height of her 10-year addiction, suffering ...

"As a 38 year old mum of 2 who has struggled for years with stress incontinence due to childbirth. I have finally found my ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation and immunology (I&I), today announced the presentation of Phase 2 ...

October 23, 2026 - DelveInsight's " BCG-Unresponsive Non-Muscle Invasive Bladder Cancer – Market Insights, Epidemiology, and Market Forecast – 2034 " report delivers an in-depth understanding of ...

(UroToday.com) The 2026 European Society of Medical Oncology (ESMO) Annual Congress held the session: Genitourinary tumour, ...

Suffering from rare testicular cancer, the tumor relapsed and invaded many organs. After 28 radiation therapy sessions ...

Learn about types of incontinence pads for MS, differences between bladder and menstrual pads, skin protection tips, insurance coverage, and when to seek medical help.

ERBB2-positive bladder cancer showed a 73.1% complete response rate with combination therapy in a phase II trial.

Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...

In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...

Bladder weakness is commonly linked with getting older, but it's a condition that can affect younger women as well. For those ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that ...